×
About 4,660 results

ALLMedicine™ Primary Aldosteronism Center

Research & Reviews  2,249 results

Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in di...
https://doi.org/10.1186/s12902-020-00656-8
BMC Endocrine Disorders; Sawamura T, Karashima S et. al.

Dec 1st, 2020 - Plasma aldosterone-to-renin ratio (ARR) is popularly used for screening primary aldosteronism (PA). Some medications, including diuretics, are known to have an effect on ARR and cause false-negative and false-positive results in PA screening. Curr...

KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Ba...
https://doi.org/10.1161/HYPERTENSIONAHA.120.15679
Hypertension (Dallas, Tex. : 1979); Chang YY, Tsai CH et. al.

Nov 30th, 2020 - Primary aldosteronism is the most common secondary endocrine form of hypertension and causes many cardiovascular injuries. KCNJ5 somatic mutations have recently been identified in aldosterone-producing adenoma. However, their impacts on left ventr...

The value of the post-captopril aldosterone/renin ratio for the diagnosis of primary al...
https://doi.org/10.1177/1470320320972032
Journal of the Renin-angiotensin-aldosterone System : JRAAS; Xiang Q, Wang W et. al.

Nov 25th, 2020 - The procedure for the captopril challenge test (CCT) in diagnosing primary aldosteronism (PA) is not standardized. We performed a meta-analysis to evaluate the controversial diagnostic value and influential factors of the post-captopril aldosteron...

High body fat percentage is associated with primary aldosteronism: a cross-sectional st...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686735
BMC Endocrine Disorders; Manosroi W, Atthakomol P

Nov 24th, 2020 - Excess aldosterone has been shown to be associated with obesity; however, there is currently a lack of data regarding the relationship between percentage of body fat and primary aldosteronism (PA), particularly pertaining to Asian populations. Fur...

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: f...
https://doi.org/10.1038/s41440-020-00569-y
Hypertension Research : Official Journal of the Japanese Society of Hypertension; Rakugi H, Yamakawa S et. al.

Nov 20th, 2020 - The nonsteroidal mineralocorticoid receptor (MR) blocker esaxerenone has demonstrated good antihypertensive activity in a variety of patients, including those with uncomplicated grade I-III hypertension, hypertension with moderate renal dysfunctio...

see more →

Guidelines  4 results

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocr...
https://academic.oup.com/jcem/article/101/5/1889/2804729
John W. Funder

Apr 30th, 2016 - For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions and recommend that a commonly used confirmatory tes.

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An E...
https://doi.org/10.1210/jc.2015-4061
The Journal of Clinical Endocrinology and Metabolism; Funder JW, Carey RM et. al.

Mar 4th, 2016 - To develop clinical practice guidelines for the management of patients with primary aldosteronism. The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist,...

Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrin...
https://doi.org/10.1507/endocrj.ej11-0133
Endocrine Journal; Nishikawa T, Omura M et. al.

Aug 10th, 2011 - The Japan Endocrine Society (JES) attempted to develop guidelines for the diagnosis and treatment of primary aldosteronism (PA). The Task Force Committee (TFC) was composed of a chair, selected by the JES, and additional experts. Systematic review...

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an end...
https://doi.org/10.1210/jc.2008-0104
The Journal of Clinical Endocrinology and Metabolism; Funder JW, Carey RM et. al.

Jun 16th, 2008 - Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, si...

see more →

Clinicaltrials.gov  2,331 results

Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in di...
https://doi.org/10.1186/s12902-020-00656-8
BMC Endocrine Disorders; Sawamura T, Karashima S et. al.

Dec 1st, 2020 - Plasma aldosterone-to-renin ratio (ARR) is popularly used for screening primary aldosteronism (PA). Some medications, including diuretics, are known to have an effect on ARR and cause false-negative and false-positive results in PA screening. Curr...

KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Ba...
https://doi.org/10.1161/HYPERTENSIONAHA.120.15679
Hypertension (Dallas, Tex. : 1979); Chang YY, Tsai CH et. al.

Nov 30th, 2020 - Primary aldosteronism is the most common secondary endocrine form of hypertension and causes many cardiovascular injuries. KCNJ5 somatic mutations have recently been identified in aldosterone-producing adenoma. However, their impacts on left ventr...

The value of the post-captopril aldosterone/renin ratio for the diagnosis of primary al...
https://doi.org/10.1177/1470320320972032
Journal of the Renin-angiotensin-aldosterone System : JRAAS; Xiang Q, Wang W et. al.

Nov 25th, 2020 - The procedure for the captopril challenge test (CCT) in diagnosing primary aldosteronism (PA) is not standardized. We performed a meta-analysis to evaluate the controversial diagnostic value and influential factors of the post-captopril aldosteron...

High body fat percentage is associated with primary aldosteronism: a cross-sectional st...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686735
BMC Endocrine Disorders; Manosroi W, Atthakomol P

Nov 24th, 2020 - Excess aldosterone has been shown to be associated with obesity; however, there is currently a lack of data regarding the relationship between percentage of body fat and primary aldosteronism (PA), particularly pertaining to Asian populations. Fur...

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: f...
https://doi.org/10.1038/s41440-020-00569-y
Hypertension Research : Official Journal of the Japanese Society of Hypertension; Rakugi H, Yamakawa S et. al.

Nov 20th, 2020 - The nonsteroidal mineralocorticoid receptor (MR) blocker esaxerenone has demonstrated good antihypertensive activity in a variety of patients, including those with uncomplicated grade I-III hypertension, hypertension with moderate renal dysfunctio...

see more →

News  71 results

Adrenal Venous Sampling Not Always Required Before Unilateral Adenoma Treatment
https://www.medscape.com/viewarticle/940852

Nov 15th, 2020 - NEW YORK (Reuters Health) - In patients with primary aldosteronism and clearly visualized unilateral adenomas, confirmatory adrenal venous sampling (AVS) may not be required prior to surgery, researchers say. "It's important to realize that AVS is...

AVS Is a 'Choke Point' for Aldosteronism Assessment in Hypertension
https://www.staging.medscape.com/viewarticle/939025

Oct 12th, 2020 - At a time when new evidence strongly suggests that roughly a fifth of patients with hypertension have primary aldosteronism as the cause, other recent findings suggest that many of these possibly tens of millions of patients with aldosterone-drive...

AVS Is a 'Choke Point' for Aldosteronism Assessment in Hypertension
https://www.medscape.com/viewarticle/939025

Oct 12th, 2020 - At a time when new evidence strongly suggests that roughly a fifth of patients with hypertension have primary aldosteronism as the cause, other recent findings suggest that many of these possibly tens of millions of patients with aldosterone-drive...

'Brand New' Data on Aldosterone in Hypertension a 'Tough Sell' to PCPs
https://www.staging.medscape.com/viewarticle/938458

Oct 1st, 2020 - Dr Jun Yang (right) and her father. Dr Yang Jun Yang, MBBS, had watched as her father, who had battled hypertension for decades, ended up on four medications that still couldn't bring his blood pressure to a healthy level. The cardiovascular endoc...

'Brand New' Data on Aldosterone in Hypertension a 'Tough Sell' to PCPs
https://www.medscape.com/viewarticle/938458

Oct 1st, 2020 - Dr Jun Yang (right) and her father. Dr Yang Jun Yang, MBBS, had watched as her father, who had battled hypertension for decades, ended up on four medications that still couldn't bring his blood pressure to a healthy level. The cardiovascular endoc...

see more →

Patient Education  5 results see all →